Cikkek nyilvánosan hozzáférhető megbízással - Inamul HaqueTovábbi információ
Sehol sem hozzáférhető: 1
pH-sensitive nanodrug carriers for codelivery of ERK inhibitor and gemcitabine enhance the inhibition of tumor growth in pancreatic cancer
P Ray, D Dutta, I Haque, G Nair, J Mohammed, M Parmer, N Kale, M Orr, ...
Molecular Pharmaceutics 18 (1), 87-100, 2020
Megbízások: US National Science Foundation, US National Institutes of Health, US …
Valahol hozzáférhető: 20
The impact of nanoparticles on the immune system: a gray zone of nanomedicine
P Ray, N Haideri, I Haque, O Mohammed, S Chakraborty, S Banerjee, ...
Journal of Immunological Sciences 5 (1), 2021
Megbízások: US National Science Foundation, US National Institutes of Health, US …
CCN5/WISP-2 expression in breast adenocarcinoma is associated with less frequent progression of the disease and suppresses the invasive phenotypes of tumor cells
S Banerjee, G Dhar, I Haque, S Kambhampati, S Mehta, K Sengupta, ...
Cancer research 68 (18), 7606-7612, 2008
Megbízások: US National Institutes of Health
Leptin-induced ER-α-positive breast cancer cell viability and migration is mediated by suppressing CCN5-signaling via activating JAK/AKT/STAT-pathway
I Haque, A Ghosh, S Acup, S Banerjee, K Dhar, A Ray, S Sarkar, ...
BMC cancer 18, 1-14, 2018
Megbízások: US Department of Veterans Affairs
CCN5/WISP-2 promotes growth arrest of triple-negative breast cancer cells through accumulation and trafficking of p27Kip1 via SKP2 and FOXO3a regulation
I Haque, S Banerjee, A De, G Maity, S Sarkar, M Majumdar, SS Jha, ...
Oncogene 34 (24), 3152-3163, 2015
Megbízások: US Department of Veterans Affairs
The MAZ transcription factor is a downstream target of the oncoprotein Cyr61/CCN1 and promotes pancreatic cancer cell invasion via CRAF–ERK signaling
G Maity, I Haque, A Ghosh, G Dhar, V Gupta, S Sarkar, I Azeem, ...
Journal of Biological Chemistry 293 (12), 4334-4349, 2018
Megbízások: US National Institutes of Health, US Department of Veterans Affairs
Pancreatic tumor cell secreted CCN1/Cyr61 promotes endothelial cell migration and aberrant neovascularization
G Maity, S Mehta, I Haque, K Dhar, S Sarkar, SK Banerjee, S Banerjee
Scientific reports 4 (1), 4995, 2014
Megbízások: US National Institutes of Health
CCN5 activation by free or encapsulated EGCG is required to render triple‐negative breast cancer cell viability and tumor progression
A Das, I Haque, P Ray, A Ghosh, D Dutta, M Quadir, A De, ...
Pharmacology research & perspectives 9 (2), e00753, 2021
Megbízások: US National Science Foundation, US National Institutes of Health, US …
The role of compounds derived from natural supplement as anticancer agents in renal cell carcinoma: a review
I Haque, A Subramanian, CH Huang, AK Godwin, PJ Van Veldhuizen, ...
International journal of molecular sciences 19 (1), 107, 2017
Megbízások: US Department of Veterans Affairs
Deficiency of CCN5/WISP-2-Driven Program in breast cancer Promotes Cancer Epithelial cells to mesenchymal stem cells and Breast Cancer growth
A Das, K Dhar, G Maity, S Sarkar, A Ghosh, I Haque, G Dhar, S Banerjee, ...
Scientific reports 7 (1), 1220, 2017
Megbízások: US National Institutes of Health, US Department of Veterans Affairs
A second-generation 2-Methoxyestradiol prodrug is effective against Barrett's adenocarcinoma in a mouse xenograft model
S Kambhampati, RA Rajewski, M Tanol, I Haque, A Das, S Banerjee, ...
Molecular cancer therapeutics 12 (3), 255-263, 2013
Megbízások: US National Institutes of Health
CYR61/CCN1 regulates dCK and CTGF and causes gemcitabine-resistant phenotype in pancreatic ductal adenocarcinoma
G Maity, A Ghosh, V Gupta, I Haque, S Sarkar, A Das, K Dhar, ...
Molecular cancer therapeutics 18 (4), 788-800, 2019
Megbízások: US Department of Veterans Affairs
Racial disparity in breast cancer: can it be mattered for prognosis and therapy
V Gupta, I Haque, J Chakraborty, S Graff, S Banerjee, SK Banerjee
Journal of cell communication and signaling 12, 119-132, 2018
Megbízások: US Department of Veterans Affairs
CCN5/WISP-2 restores ER-∝ in normal and neoplastic breast cells and sensitizes triple negative breast cancer cells to tamoxifen
S Sarkar, A Ghosh, S Banerjee, G Maity, A Das, MA Larson, V Gupta, ...
Oncogenesis 6 (5), e340-e340, 2017
Megbízások: US National Institutes of Health, US Department of Veterans Affairs
Downregulation of miR-506-3p facilitates EGFR-TKI resistance through induction of sonic hedgehog signaling in non-small-cell lung cancer cell lines
I Haque, HI Kawsar, H Motes, M Sharma, S Banerjee, SK Banerjee, ...
International Journal of Molecular Sciences 21 (23), 9307, 2020
Megbízások: US National Institutes of Health, US Department of Veterans Affairs
Aspirin suppresses tumor cell-induced angiogenesis and their incongruity
G Maity, J Chakraborty, A Ghosh, I Haque, S Banerjee, SK Banerjee
Journal of cell communication and signaling 13, 491-502, 2019
Megbízások: US Department of Veterans Affairs
The miRacle in pancreatic cancer by miRNAs: tiny angels or devils in disease progression
Z Hawa, I Haque, A Ghosh, S Banerjee, LC Harris, SK Banerjee
International Journal of Molecular Sciences 17 (6), 809, 2016
Megbízások: US Department of Veterans Affairs
Human pancreatic cancer progression: an anarchy among CCN-siblings
SK Banerjee, G Maity, I Haque, A Ghosh, S Sarkar, V Gupta, ...
Journal of cell communication and signaling 10, 207-216, 2016
Megbízások: US Department of Veterans Affairs
Identifying protein stabilizing ligands using GroEL
S Naik, I Haque, N Degner, B Kornilayev, G Bomhoff, J Hodges, ...
Biopolymers: Original Research on Biomolecules 93 (3), 237-251, 2010
Megbízások: US National Institutes of Health
2-Methoxyestradiol Inhibits Barrett's Esophageal Adenocarcinoma Growth and Differentiation through Differential Regulation of the β-Catenin–E-Cadherin Axis
S Kambhampati, S Banerjee, K Dhar, S Mehta, I Haque, G Dhar, ...
Molecular cancer therapeutics 9 (3), 523-534, 2010
Megbízások: US National Institutes of Health
A publikációs és a finanszírozási adatokat számítógépes program határozza meg, automatikusan.